Suberoylanilide Hydroxamic Acid (SAHA)-Induced Dynamics of a Human Histone Deacetylase Protein Interaction Network

Histone deacetylases (HDACs) are targets for cancer therapy. Suberoylanilide hydroxamic acid (SAHA) is an HDAC inhibitor approved by the U.S. Food and Drug Administration for the treatment of cutaneous T-cell lymphoma. To obtain a better mechanistic understanding of the Sin3/HDAC complex in cancer,...

Full description

Saved in:
Bibliographic Details
Published in:Mol Cell Proteomics
Main Authors: Sardiu, Mihaela E., Smith, Karen T., Groppe, Brad D., Gilmore, Joshua M., Saraf, Anita, Egidy, Rhonda, Peak, Allison, Seidel, Chris W., Florens, Laurence, Workman, Jerry L., Washburn, Michael P.
Format: Artigo
Language:Inglês
Published: The American Society for Biochemistry and Molecular Biology 2014
Subjects:
Regular Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4223495/
https://ncbi.nlm.nih.gov/pubmed/25073741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M113.037127
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items